DDX5 and psoriasis: Based on immunoblotting and immunofluorescence staining, expression of DDX5 protein was reduced in whole skin lesions from patients with AD and psoriasis (Fig. 1b,c) and slightly increased in epidermal tissues from skin carcinomas (Extended Data Fig. 1c), compared with healthy skin.